BIOLINERX
Careers | Contact Us
search

Press Releases
November 20, 2017
Enrollment to COMBAT study has been completed; full topline results expected in H2 2018 as planned

November 9, 2017
Management to hold a conference call at 10:00 a.m. EST
November 2, 2017
Preclinical data demonstrate that BL-8040 mobilizes a significant number of these HSCs compared to G-CSF, thus potentially improving graft quality
October 18, 2017
Combination trial of BL-8040 and atezolizumab is part of initiative for the development of novel cancer immunotherapy combinations
September 26, 2017
The BATTLE trial will investigate the combination of BL-8040 and atezolizumab under cancer immunotherapy collaboration
August 21, 2017
GENESIS is a Phase 3 trial for the mobilization of hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

Initiation of study expected by end of 2017

1-10  Out of  268
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27 
Next